Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
Insilico Medicine has made headlines for discovering novel compounds for fibrosis using AI-generated models, further ...
A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...
A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback